Abstract |
Quercetin, a widely distributed bioflavonoid, has been shown to induce growth inhibition in certain cancer cell types. In the present study we have pursued the mechanism of growth inhibition in MCF-7 human breast cancer cells. Quercetin treatment resulted in the accumulation of cells specifically at G2/M phase of the cell cycle. Mitotic index measured by MPM2 staining clearly showed that cells were transiently accumulated in M phase, 24 h after treatment. The transient M phase accumulation was accompanied by a transient increase in the levels of cyclin B1 and Cdc2 kinase activity. However, 24 h or longer treatment caused a marked accumulation of cells in G2 instead of M phase. Levels of cyclin B1 and cyclin B1-associated Cdc2 kinase activity were also decreased. We also found that quercetin markedly increased Cdk-inhibitor p21CIP1/WAF1 protein level after treatment for 48 h or longer, and the induction of p21CIP1/WAF1 increased its association with Cdc2-cyclin B1 complex, however, up-regulation of p53 by quercetin was not observed. Quercetin also induced significant apoptosis in MCF-7 cells in addition to cell cycle arrest, and the induction of apoptosis was markedly blocked by antisense p21CIP1/WAF1 expression. The present data, therefore, demonstrate that a flavonoid quercetin induces growth inhibition in the human breast carcinoma cell line MCF-7 through at least two different mechanisms; by inhibiting cell cycle progression through transient M phase accumulation and subsequent G2 arrest, and by inducing apoptosis.
|
Authors | J A Choi, J Y Kim, J Y Lee, C M Kang, H J Kwon, Y D Yoo, T W Kim, Y S Lee, S J Lee |
Journal | International journal of oncology
(Int J Oncol)
Vol. 19
Issue 4
Pg. 837-44
(Oct 2001)
ISSN: 1019-6439 [Print] Greece |
PMID | 11562764
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antisense Elements (Genetics)
- CDKN1A protein, human
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- Tumor Suppressor Protein p53
- Quercetin
- Cyclin-Dependent Kinases
- Bisbenzimidazole
|
Topics |
- Antisense Elements (Genetics)
(pharmacology)
- Apoptosis
(drug effects)
- Bisbenzimidazole
- Breast Neoplasms
(drug therapy, pathology)
- Cell Cycle
(drug effects)
- Cell Division
(drug effects)
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinases
(metabolism)
- Cyclins
(genetics, metabolism)
- Female
- Flow Cytometry
- Fluorescent Antibody Technique
- Humans
- Precipitin Tests
- Quercetin
(therapeutic use)
- Transfection
- Tumor Cells, Cultured
(drug effects)
- Tumor Suppressor Protein p53
(metabolism)
|